The results showed that pathway in cancer, the P13K-Akt signaling pathway, the MAPK signaling pathway, the lipid and atheromatocellular cirrhosis pathway, and the atherosclerosis pathway were the main pathways for the prevention and treatment of irritable bowel syndrome. The gene discussed is AKT1; the disease is irritable bowel syndrome.